These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 15639124)

  • 1. Report of a Muscular Dystrophy Campaign funded workshop Birmingham, UK, January 16th 2004. Osteoporosis in Duchenne muscular dystrophy; its prevalence, treatment and prevention.
    Quinlivan R; Roper H; Davie M; Shaw NJ; McDonagh J; Bushby K
    Neuromuscul Disord; 2005 Jan; 15(1):72-9. PubMed ID: 15639124
    [No Abstract]   [Full Text] [Related]  

  • 2. Muscular Dystrophy Campaign Funded Workshop on Management of Scoliosis in Duchenne Muscular Dystrophy 24 January 2005, London, UK.
    Muntoni F; Bushby K; Manzur AY
    Neuromuscul Disord; 2006 Mar; 16(3):210-9. PubMed ID: 16497502
    [No Abstract]   [Full Text] [Related]  

  • 3. Taking steps towards reducing osteoporosis in Duchenne muscular dystrophy.
    Bachrach LK
    Neuromuscul Disord; 2005 Jan; 15(1):86-7. PubMed ID: 15639126
    [No Abstract]   [Full Text] [Related]  

  • 4. [Alendronate treatment of osteoporosis secondary to Duchenne muscular dystrophy].
    Palomo Atance E; Ballester Herrera MJ; Márquez de La Plata MA; Medina Cano E; Carmona Vilchez RM
    An Pediatr (Barc); 2011 Feb; 74(2):122-5. PubMed ID: 21169073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone health in children with neuromuscular disorders.
    Ness K; Apkon SD
    J Pediatr Rehabil Med; 2014; 7(2):133-42. PubMed ID: 25096865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop: Morbidity due to osteoporosis in DMD: The Path Forward May 12-13, 2016, Bethesda, Maryland, USA.
    Ward LM; Kinnett K; Bonewald L;
    Neuromuscul Disord; 2018 Jan; 28(1):64-76. PubMed ID: 28756052
    [No Abstract]   [Full Text] [Related]  

  • 7. Bone Health and Osteoporosis Management of the Patient With Duchenne Muscular Dystrophy.
    Ward LM; Hadjiyannakis S; McMillan HJ; Noritz G; Weber DR
    Pediatrics; 2018 Oct; 142(Suppl 2):S34-S42. PubMed ID: 30275247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Moving Beyond the 2018 Minimum International Care Considerations for Osteoporosis Management in Duchenne Muscular Dystrophy (DMD): Meeting Report from the 3rd International Muscle-Bone Interactions Meeting 7th and 14th November 2022.
    Phung K; Crabtree N; Connolly AM; Furlong P; Hoffman EP; Jackowski SA; Jayash SN; Johnson A; Koujok K; Munns CF; Niks E; Rauch F; Schrader R; Turner C; Vroom E; Weber DR; Wong BL; Guglieri M; Ward LM; Wong SC
    J Neuromuscul Dis; 2024; 11(1):233-252. PubMed ID: 37980681
    [No Abstract]   [Full Text] [Related]  

  • 9. 170th ENMC International Workshop: bone protection for corticosteroid treated Duchenne muscular dystrophy. 27-29 November 2009, Naarden, The Netherlands.
    Quinlivan R; Shaw N; Bushby K
    Neuromuscul Disord; 2010 Nov; 20(11):761-9. PubMed ID: 20724157
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone mineral density and fractures in boys with Duchenne muscular dystrophy.
    Larson CM; Henderson RC
    J Pediatr Orthop; 2000; 20(1):71-4. PubMed ID: 10641693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fracture in Duchenne Muscular Dystrophy: Natural History and Vitamin D Deficiency.
    Perera N; Sampaio H; Woodhead H; Farrar M
    J Child Neurol; 2016 Aug; 31(9):1181-7. PubMed ID: 27221372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased bone density in ambulatory patients with duchenne muscular dystrophy.
    Aparicio LF; Jurkovic M; DeLullo J
    J Pediatr Orthop; 2002; 22(2):179-81. PubMed ID: 11856925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vertebral fractures in boys with Duchenne muscular dystrophy.
    Bothwell JE; Gordon KE; Dooley JM; MacSween J; Cummings EA; Salisbury S
    Clin Pediatr (Phila); 2003 May; 42(4):353-6. PubMed ID: 12800730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pain, osteopenia and body composition of 22 patients with Duchenne muscular dystrophy: a descriptive study].
    Douvillez B; Braillon P; Hodgkinson I; Berard C
    Ann Readapt Med Phys; 2005 Nov; 48(8):616-22. PubMed ID: 16023755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting-enzyme inhibitors versus steroids as first-line drug treatment in Duchenne muscular dystrophy.
    Chabrier S; Desguerre I; Porte M; Payet C; Rivier F;
    Dev Med Child Neurol; 2010 Nov; 52(11):1067-8. PubMed ID: 20636389
    [No Abstract]   [Full Text] [Related]  

  • 16. Association of Duchenne muscular dystrophy with autism spectrum disorder.
    Wu JY; Kuban KC; Allred E; Shapiro F; Darras BT
    J Child Neurol; 2005 Oct; 20(10):790-5. PubMed ID: 16417872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone health measures in glucocorticoid-treated ambulatory boys with Duchenne muscular dystrophy.
    Tian C; Wong BL; Hornung L; Khoury JC; Miller L; Bange J; Rybalsky I; Rutter MM
    Neuromuscul Disord; 2016 Nov; 26(11):760-767. PubMed ID: 27614576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 2009 perspective on the 2004 American Thoracic Society statement, "respiratory care of the patient with Duchenne muscular dystrophy".
    Finder JD
    Pediatrics; 2009 May; 123 Suppl 4():S239-41. PubMed ID: 19420152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery for scoliosis in Duchenne muscular dystrophy.
    Cheuk DK; Wong V; Wraige E; Baxter P; Cole A; N'Diaye T; Mayowe V
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005375. PubMed ID: 17253553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bone quality in Duchenne muscular dystrophy.
    Finsterer J; Strobl W
    J Endocrinol Invest; 2022 Jun; 45(6):1265-1266. PubMed ID: 35267176
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.